

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.13946198 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.13946198 |
| 3 | fatty acid elongation (GO:0030497) | 6.50831878 |
| 4 | nuclear pore complex assembly (GO:0051292) | 5.46560564 |
| 5 | amyloid precursor protein metabolic process (GO:0042982) | 4.98428129 |
| 6 | response to lipoprotein particle (GO:0055094) | 4.63641521 |
| 7 | myelination (GO:0042552) | 4.55057072 |
| 8 | ensheathment of neurons (GO:0007272) | 4.54513699 |
| 9 | axon ensheathment (GO:0008366) | 4.54513699 |
| 10 | response to methylmercury (GO:0051597) | 4.43154175 |
| 11 | nuclear pore organization (GO:0006999) | 4.40910364 |
| 12 | thrombin receptor signaling pathway (GO:0070493) | 4.38714101 |
| 13 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.35496587 |
| 14 | regulation of histone H3-K9 methylation (GO:0051570) | 4.28883502 |
| 15 | amyloid precursor protein catabolic process (GO:0042987) | 4.23143685 |
| 16 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.19502605 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.09600627 |
| 18 | pore complex assembly (GO:0046931) | 4.07470839 |
| 19 | cholesterol biosynthetic process (GO:0006695) | 4.03073677 |
| 20 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.01570734 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.96988375 |
| 22 | negative regulation of histone methylation (GO:0031061) | 3.94454558 |
| 23 | regulation of collateral sprouting (GO:0048670) | 3.85982965 |
| 24 | megakaryocyte development (GO:0035855) | 3.77964418 |
| 25 | protein neddylation (GO:0045116) | 3.77582951 |
| 26 | sterol biosynthetic process (GO:0016126) | 3.75238249 |
| 27 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.71836460 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.69236900 |
| 29 | myelin maintenance (GO:0043217) | 3.68828605 |
| 30 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.61693923 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.59237340 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.58688731 |
| 33 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.58614917 |
| 34 | platelet aggregation (GO:0070527) | 3.45297104 |
| 35 | glycosylceramide metabolic process (GO:0006677) | 3.38422469 |
| 36 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.37721637 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.34442843 |
| 38 | regulation of platelet aggregation (GO:0090330) | 3.32363795 |
| 39 | negative regulation of neurotransmitter transport (GO:0051589) | 3.31483177 |
| 40 | developmental pigmentation (GO:0048066) | 3.31314909 |
| 41 | L-phenylalanine catabolic process (GO:0006559) | 3.22684675 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.22684675 |
| 43 | regulation of translational fidelity (GO:0006450) | 3.21648051 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.21110983 |
| 45 | nerve growth factor signaling pathway (GO:0038180) | 3.20776062 |
| 46 | eye photoreceptor cell differentiation (GO:0001754) | 3.20288259 |
| 47 | photoreceptor cell differentiation (GO:0046530) | 3.20288259 |
| 48 | negative T cell selection (GO:0043383) | 3.20030842 |
| 49 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.19259537 |
| 50 | isoprenoid biosynthetic process (GO:0008299) | 3.17893224 |
| 51 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.16262923 |
| 52 | very long-chain fatty acid metabolic process (GO:0000038) | 3.14596303 |
| 53 | positive regulation of granulocyte differentiation (GO:0030854) | 3.13931067 |
| 54 | L-amino acid import (GO:0043092) | 3.12496543 |
| 55 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.05503141 |
| 56 | actin nucleation (GO:0045010) | 3.04017436 |
| 57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01099997 |
| 58 | positive regulation of humoral immune response (GO:0002922) | 3.00742057 |
| 59 | blood coagulation, intrinsic pathway (GO:0007597) | 3.00082866 |
| 60 | signal peptide processing (GO:0006465) | 2.99530982 |
| 61 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.97644784 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.97346852 |
| 63 | regulation of lipoprotein metabolic process (GO:0050746) | 2.95064771 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93955736 |
| 65 | nucleotide transmembrane transport (GO:1901679) | 2.90363004 |
| 66 | regulation of platelet activation (GO:0010543) | 2.88691052 |
| 67 | mast cell activation (GO:0045576) | 2.86109621 |
| 68 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.85533649 |
| 69 | oligodendrocyte differentiation (GO:0048709) | 2.84263484 |
| 70 | negative regulation of norepinephrine secretion (GO:0010700) | 2.82799423 |
| 71 | establishment of mitochondrion localization (GO:0051654) | 2.82485625 |
| 72 | response to dietary excess (GO:0002021) | 2.80860510 |
| 73 | magnesium ion transport (GO:0015693) | 2.78778653 |
| 74 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.78155645 |
| 75 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.76153396 |
| 76 | import into cell (GO:0098657) | 2.72234883 |
| 77 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.71687395 |
| 78 | positive regulation of B cell mediated immunity (GO:0002714) | 2.71687395 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.71285227 |
| 80 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.70623122 |
| 81 | negative regulation of cell killing (GO:0031342) | 2.70444073 |
| 82 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.70444073 |
| 83 | homotypic cell-cell adhesion (GO:0034109) | 2.69472378 |
| 84 | melanin biosynthetic process (GO:0042438) | 2.67611408 |
| 85 | response to muramyl dipeptide (GO:0032495) | 2.66698545 |
| 86 | protein palmitoylation (GO:0018345) | 2.65718037 |
| 87 | beta-amyloid metabolic process (GO:0050435) | 2.65282742 |
| 88 | astrocyte differentiation (GO:0048708) | 2.64909846 |
| 89 | negative regulation of chemokine production (GO:0032682) | 2.64524010 |
| 90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.62977088 |
| 91 | regulation of regulatory T cell differentiation (GO:0045589) | 2.62533722 |
| 92 | purine nucleobase biosynthetic process (GO:0009113) | 2.62355134 |
| 93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62149662 |
| 94 | GPI anchor biosynthetic process (GO:0006506) | 2.61807438 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.61207859 |
| 96 | L-phenylalanine metabolic process (GO:0006558) | 2.61207859 |
| 97 | adenosine receptor signaling pathway (GO:0001973) | 2.60730183 |
| 98 | positive regulation of glial cell differentiation (GO:0045687) | 2.60590694 |
| 99 | GPI anchor metabolic process (GO:0006505) | 2.60257608 |
| 100 | glycerophospholipid catabolic process (GO:0046475) | 2.57228663 |
| 101 | melanin metabolic process (GO:0006582) | 2.56368110 |
| 102 | autophagic vacuole fusion (GO:0000046) | 2.55768899 |
| 103 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.54987104 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 2.54972503 |
| 105 | modulation by symbiont of host defense response (GO:0052031) | 2.54972503 |
| 106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.54972503 |
| 107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.54972503 |
| 108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.54972503 |
| 109 | modulation by symbiont of host immune response (GO:0052553) | 2.54972503 |
| 110 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.54653238 |
| 111 | tRNA aminoacylation for protein translation (GO:0006418) | 2.54215944 |
| 112 | amino acid import (GO:0043090) | 2.51814165 |
| 113 | positive regulation of gliogenesis (GO:0014015) | 2.51376686 |
| 114 | tyrosine metabolic process (GO:0006570) | 2.51104403 |
| 115 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.50478202 |
| 116 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.50387050 |
| 117 | regulation of B cell mediated immunity (GO:0002712) | 2.50313541 |
| 118 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.50120452 |
| 119 | neutrophil activation (GO:0042119) | 2.49942183 |
| 120 | mast cell degranulation (GO:0043303) | 2.49651849 |
| 121 | mast cell activation involved in immune response (GO:0002279) | 2.49651849 |
| 122 | lymph node development (GO:0048535) | 2.48907395 |
| 123 | amino acid activation (GO:0043038) | 2.48488754 |
| 124 | tRNA aminoacylation (GO:0043039) | 2.48488754 |
| 125 | regulation of hypersensitivity (GO:0002883) | 2.47798373 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.47188117 |
| 127 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.47188117 |
| 128 | membrane protein ectodomain proteolysis (GO:0006509) | 2.46465119 |
| 129 | glutathione biosynthetic process (GO:0006750) | 2.44598689 |
| 130 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.44506568 |
| 131 | mitochondrial calcium ion transport (GO:0006851) | 2.44273584 |
| 132 | negative regulation of acute inflammatory response (GO:0002674) | 2.44068167 |
| 133 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.43881871 |
| 134 | regulation of histone H3-K4 methylation (GO:0051569) | 2.43567844 |
| 135 | acyl-CoA biosynthetic process (GO:0071616) | 2.43530071 |
| 136 | thioester biosynthetic process (GO:0035384) | 2.43530071 |
| 137 | response to interleukin-15 (GO:0070672) | 2.43204449 |
| 138 | intracellular pH reduction (GO:0051452) | 2.42487055 |
| 139 | positive regulation of B cell differentiation (GO:0045579) | 2.42148185 |
| 140 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.42142988 |
| 141 | drug transmembrane transport (GO:0006855) | 2.42000975 |
| 142 | leukocyte aggregation (GO:0070486) | 2.41348158 |
| 143 | positive regulation of blood coagulation (GO:0030194) | 2.40554557 |
| 144 | positive regulation of hemostasis (GO:1900048) | 2.40554557 |
| 145 | respiratory burst (GO:0045730) | 2.40502801 |
| 146 | leukocyte degranulation (GO:0043299) | 2.39434374 |
| 147 | secondary metabolite biosynthetic process (GO:0044550) | 2.39230104 |
| 148 | ribosomal small subunit biogenesis (GO:0042274) | 2.38398925 |
| 149 | tolerance induction (GO:0002507) | 2.38309158 |
| 150 | enteric nervous system development (GO:0048484) | 2.38202648 |
| 151 | pH reduction (GO:0045851) | 2.38141765 |
| 152 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.37546082 |
| 153 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.37546082 |
| 154 | positive regulation of macrophage differentiation (GO:0045651) | 2.37141364 |
| 155 | regulation of RNA export from nucleus (GO:0046831) | 2.35786766 |
| 156 | positive regulation of histone methylation (GO:0031062) | 2.35297854 |
| 157 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.34783109 |
| 158 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.34649272 |
| 159 | maturation of SSU-rRNA (GO:0030490) | 2.34138250 |
| 160 | platelet formation (GO:0030220) | 2.33806342 |
| 161 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.33151057 |
| 162 | thymic T cell selection (GO:0045061) | 2.33109760 |
| 163 | response to nerve growth factor (GO:1990089) | 2.32955127 |
| 164 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.32955127 |
| 165 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.32759897 |
| 166 | viral entry into host cell (GO:0046718) | 2.31821008 |
| 167 | protein export from nucleus (GO:0006611) | 2.31815599 |
| 168 | T-helper 1 type immune response (GO:0042088) | 2.31677962 |
| 169 | nucleobase biosynthetic process (GO:0046112) | 2.31352316 |
| 170 | T cell proliferation (GO:0042098) | 2.31252367 |
| 171 | T cell selection (GO:0045058) | 2.31192095 |
| 172 | proline biosynthetic process (GO:0006561) | 2.30478625 |
| 173 | protein localization to microtubule (GO:0035372) | 2.30065808 |
| 174 | regulation of integrin activation (GO:0033623) | 2.29921014 |
| 175 | granulocyte activation (GO:0036230) | 2.29612191 |
| 176 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.29287328 |
| 177 | cranial nerve development (GO:0021545) | 2.29191948 |
| 178 | positive regulation of pseudopodium assembly (GO:0031274) | 2.28929631 |
| 179 | regulation of gamma-delta T cell activation (GO:0046643) | 2.28774103 |
| 180 | localization within membrane (GO:0051668) | 2.28633807 |
| 181 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.28368838 |
| 182 | entry into host (GO:0044409) | 2.27505904 |
| 183 | entry into other organism involved in symbiotic interaction (GO:0051828) | 2.27505904 |
| 184 | movement in host environment (GO:0052126) | 2.27505904 |
| 185 | entry into host cell (GO:0030260) | 2.27505904 |
| 186 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 2.27505904 |
| 187 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 2.27505904 |
| 188 | regulation of vacuole organization (GO:0044088) | 2.27373525 |
| 189 | histone H2B ubiquitination (GO:0033523) | 2.26908191 |
| 190 | B cell mediated immunity (GO:0019724) | 2.26834609 |
| 191 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.26293389 |
| 192 | positive regulation of isotype switching (GO:0045830) | 2.25943309 |
| 193 | sphingomyelin metabolic process (GO:0006684) | 2.25548375 |
| 194 | cofactor catabolic process (GO:0051187) | 2.25047865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.89879242 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.01766333 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.40175384 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.14985567 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05207570 |
| 6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.71383620 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.61636348 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57976851 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55150471 |
| 10 | * MYC_22102868_ChIP-Seq_BL_Human | 2.46681850 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37753532 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.28229310 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.25713935 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25677903 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20591262 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18865742 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16438955 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10167260 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08822413 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07719592 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03339687 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.03215564 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02948508 |
| 24 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.00379068 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.00147878 |
| 26 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.97071460 |
| 27 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93793619 |
| 28 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.88795863 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87323178 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86499388 |
| 31 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82775420 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82733180 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76286453 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.74097590 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73301391 |
| 36 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.72211428 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.71546500 |
| 38 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.70627963 |
| 39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.67842391 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.66749404 |
| 41 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.66094080 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65415456 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64864920 |
| 44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61224871 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.61106207 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60683398 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59320205 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.57509826 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.57203498 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56929355 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54816430 |
| 52 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53938335 |
| 53 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52587241 |
| 54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.51188706 |
| 55 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.50642839 |
| 56 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.50535655 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.48366856 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47879325 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.47864077 |
| 60 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47519109 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.46074934 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45688507 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44693307 |
| 64 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44001914 |
| 65 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.43256034 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42523435 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40632851 |
| 68 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.40177532 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39921157 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37654387 |
| 71 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36990864 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36591231 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35859447 |
| 74 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35202381 |
| 75 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34975898 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34803585 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34496912 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34432811 |
| 79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33852379 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33387892 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31517213 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30418038 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30071784 |
| 84 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.29858023 |
| 85 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29772572 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28154185 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27094728 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26539471 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25656450 |
| 90 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.24896255 |
| 91 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23811809 |
| 92 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.23570860 |
| 93 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22517920 |
| 94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22305542 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21098494 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20511428 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20511428 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17643900 |
| 99 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17607266 |
| 100 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17289038 |
| 101 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16929461 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16769163 |
| 103 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16130732 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15912691 |
| 105 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15478217 |
| 106 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14830960 |
| 107 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14456110 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14194829 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13894755 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13856057 |
| 111 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13768002 |
| 112 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12991084 |
| 113 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.12792635 |
| 114 | MAF_26560356_Chip-Seq_TH2_Human | 1.12537843 |
| 115 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.12420735 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11695444 |
| 117 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10999567 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10578071 |
| 119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10139142 |
| 120 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09243728 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07129284 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06353660 |
| 123 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.05928922 |
| 124 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05607130 |
| 125 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05603539 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03962215 |
| 127 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.03192356 |
| 128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02766148 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01934571 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01789740 |
| 131 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01505942 |
| 132 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00727023 |
| 133 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99610449 |
| 134 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99132638 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99114586 |
| 136 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99026020 |
| 137 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98382843 |
| 138 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97588769 |
| 139 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97541440 |
| 140 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97359987 |
| 141 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97289262 |
| 142 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96808483 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96670625 |
| 144 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96523972 |
| 145 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95367812 |
| 146 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94201488 |
| 147 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93786085 |
| 148 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93665592 |
| 149 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93083096 |
| 150 | MYB_26560356_Chip-Seq_TH2_Human | 0.92042206 |
| 151 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90644627 |
| 152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90635095 |
| 153 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90292616 |
| 154 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90263447 |
| 155 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89828380 |
| 156 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89068822 |
| 157 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.87754716 |
| 158 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86296648 |
| 159 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85957204 |
| 160 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.85934745 |
| 161 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84069799 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83309318 |
| 163 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82018875 |
| 164 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81158079 |
| 165 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80920567 |
| 166 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80674425 |
| 167 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80628057 |
| 168 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80220044 |
| 169 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79288528 |
| 170 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78782523 |
| 171 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78750635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.21637904 |
| 2 | MP0005171_absent_coat_pigmentation | 3.35520443 |
| 3 | MP0005408_hypopigmentation | 3.22861157 |
| 4 | MP0000372_irregular_coat_pigmentation | 3.11060075 |
| 5 | MP0003136_yellow_coat_color | 3.06671163 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.87247128 |
| 7 | MP0004381_abnormal_hair_follicle | 2.75816348 |
| 8 | MP0008057_abnormal_DNA_replication | 2.61486435 |
| 9 | MP0002009_preneoplasia | 2.50870278 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.32669775 |
| 11 | MP0003690_abnormal_glial_cell | 2.31377182 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.25257430 |
| 13 | MP0006082_CNS_inflammation | 2.23580223 |
| 14 | MP0003195_calcinosis | 2.22073017 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.19884991 |
| 16 | MP0009840_abnormal_foam_cell | 2.09801986 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.09667976 |
| 18 | MP0002398_abnormal_bone_marrow | 2.08569314 |
| 19 | MP0005174_abnormal_tail_pigmentation | 2.05990867 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.04931101 |
| 21 | MP0003724_increased_susceptibility_to | 2.01623361 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.97043582 |
| 23 | MP0008004_abnormal_stomach_pH | 1.96185174 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.88932420 |
| 25 | MP0000703_abnormal_thymus_morphology | 1.86373430 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.81054626 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.80488437 |
| 28 | MP0004885_abnormal_endolymph | 1.80368393 |
| 29 | MP0002419_abnormal_innate_immunity | 1.77487969 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.76004202 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.74654142 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.74267110 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.73502121 |
| 34 | MP0009697_abnormal_copulation | 1.70996742 |
| 35 | MP0002722_abnormal_immune_system | 1.66934827 |
| 36 | MP0004043_abnormal_pH_regulation | 1.65825695 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.65035295 |
| 38 | MP0003077_abnormal_cell_cycle | 1.63867524 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.62995070 |
| 40 | MP0001730_embryonic_growth_arrest | 1.62579981 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.60457045 |
| 42 | MP0003634_abnormal_glial_cell | 1.58326342 |
| 43 | MP0005387_immune_system_phenotype | 1.58225466 |
| 44 | MP0001790_abnormal_immune_system | 1.58225466 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.56318501 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.51416138 |
| 47 | MP0005025_abnormal_response_to | 1.51352779 |
| 48 | MP0008058_abnormal_DNA_repair | 1.49534247 |
| 49 | MP0003329_amyloid_beta_deposits | 1.49341728 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.49062766 |
| 51 | MP0004742_abnormal_vestibular_system | 1.48506764 |
| 52 | MP0005409_darkened_coat_color | 1.45815479 |
| 53 | MP0002429_abnormal_blood_cell | 1.44684662 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.43931321 |
| 55 | MP0005360_urolithiasis | 1.43650104 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.36975193 |
| 57 | MP0000604_amyloidosis | 1.36595067 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.36591524 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.36248355 |
| 60 | MP0009785_altered_susceptibility_to | 1.35594185 |
| 61 | MP0001915_intracranial_hemorrhage | 1.35438311 |
| 62 | MP0002006_tumorigenesis | 1.35163513 |
| 63 | MP0001851_eye_inflammation | 1.34263271 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.34253216 |
| 65 | MP0000490_abnormal_crypts_of | 1.33036528 |
| 66 | MP0002723_abnormal_immune_serum | 1.32872293 |
| 67 | MP0003303_peritoneal_inflammation | 1.32378962 |
| 68 | MP0003436_decreased_susceptibility_to | 1.31527093 |
| 69 | MP0002148_abnormal_hypersensitivity_rea | 1.31166197 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.30487596 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.30050772 |
| 72 | MP0000383_abnormal_hair_follicle | 1.29775370 |
| 73 | MP0000350_abnormal_cell_proliferation | 1.29671453 |
| 74 | MP0003718_maternal_effect | 1.27320584 |
| 75 | MP0009278_abnormal_bone_marrow | 1.27021371 |
| 76 | MP0001905_abnormal_dopamine_level | 1.26376337 |
| 77 | MP0003866_abnormal_defecation | 1.22526689 |
| 78 | MP0008877_abnormal_DNA_methylation | 1.22321745 |
| 79 | MP0005671_abnormal_response_to | 1.22065853 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 1.21913290 |
| 81 | MP0000685_abnormal_immune_system | 1.18651669 |
| 82 | MP0001485_abnormal_pinna_reflex | 1.18501325 |
| 83 | MP0002452_abnormal_antigen_presenting | 1.17820998 |
| 84 | MP0003632_abnormal_nervous_system | 1.16654971 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.16456029 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.14502962 |
| 87 | MP0005451_abnormal_body_composition | 1.14400575 |
| 88 | MP0001529_abnormal_vocalization | 1.14141903 |
| 89 | MP0005365_abnormal_bile_salt | 1.13793308 |
| 90 | MP0010678_abnormal_skin_adnexa | 1.13673816 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 1.12885360 |
| 92 | MP0000313_abnormal_cell_death | 1.12227486 |
| 93 | MP0002420_abnormal_adaptive_immunity | 1.10169765 |
| 94 | MP0001545_abnormal_hematopoietic_system | 1.09936050 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 1.09936050 |
| 96 | MP0001819_abnormal_immune_cell | 1.09359508 |
| 97 | MP0000462_abnormal_digestive_system | 1.09242665 |
| 98 | MP0009763_increased_sensitivity_to | 1.09125560 |
| 99 | MP0000858_altered_metastatic_potential | 1.08165572 |
| 100 | MP0002938_white_spotting | 1.08105836 |
| 101 | MP0001800_abnormal_humoral_immune | 1.06708206 |
| 102 | MP0001835_abnormal_antigen_presentation | 1.06654263 |
| 103 | MP0002638_abnormal_pupillary_reflex | 1.06583644 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 1.06576652 |
| 105 | MP0005621_abnormal_cell_physiology | 1.03841152 |
| 106 | MP0002229_neurodegeneration | 1.03785415 |
| 107 | MP0004147_increased_porphyrin_level | 1.01865040 |
| 108 | MP0008260_abnormal_autophagy | 1.01791000 |
| 109 | MP0005310_abnormal_salivary_gland | 1.00943342 |
| 110 | MP0002095_abnormal_skin_pigmentation | 1.00785978 |
| 111 | MP0003631_nervous_system_phenotype | 0.98197890 |
| 112 | MP0003633_abnormal_nervous_system | 0.97906849 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.97477981 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.96308165 |
| 115 | MP0002933_joint_inflammation | 0.95975667 |
| 116 | MP0003828_pulmonary_edema | 0.95738573 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.95315817 |
| 118 | MP0005384_cellular_phenotype | 0.94509025 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.93694418 |
| 120 | MP0001697_abnormal_embryo_size | 0.93497093 |
| 121 | MP0000358_abnormal_cell_content/ | 0.91077040 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.90557001 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.89587986 |
| 124 | MP0008007_abnormal_cellular_replicative | 0.89483050 |
| 125 | MP0004270_analgesia | 0.88120293 |
| 126 | MP0003075_altered_response_to | 0.87583215 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.86178225 |
| 128 | MP0005083_abnormal_biliary_tract | 0.85630029 |
| 129 | MP0002118_abnormal_lipid_homeostasis | 0.84619191 |
| 130 | MP0004142_abnormal_muscle_tone | 0.84319722 |
| 131 | MP0000371_diluted_coat_color | 0.83896432 |
| 132 | MP0000343_altered_response_to | 0.83838568 |
| 133 | MP0002080_prenatal_lethality | 0.83245500 |
| 134 | MP0002086_abnormal_extraembryonic_tissu | 0.82042169 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.81089402 |
| 136 | MP0008469_abnormal_protein_level | 0.81019959 |
| 137 | MP0002735_abnormal_chemical_nociception | 0.80218783 |
| 138 | MP0004947_skin_inflammation | 0.79758673 |
| 139 | MP0001348_abnormal_lacrimal_gland | 0.79387870 |
| 140 | MP0000566_synostosis | 0.79188449 |
| 141 | MP0005501_abnormal_skin_physiology | 0.77690336 |
| 142 | MP0003448_altered_tumor_morphology | 0.77538912 |
| 143 | MP0001970_abnormal_pain_threshold | 0.76034365 |
| 144 | MP0005645_abnormal_hypothalamus_physiol | 0.75785156 |
| 145 | MP0005332_abnormal_amino_acid | 0.75412706 |
| 146 | MP0009765_abnormal_xenobiotic_induced | 0.75131604 |
| 147 | MP0002998_abnormal_bone_remodeling | 0.74547040 |
| 148 | MP0002405_respiratory_system_inflammati | 0.74430436 |
| 149 | MP0005085_abnormal_gallbladder_physiolo | 0.74048856 |
| 150 | MP0001853_heart_inflammation | 0.73985249 |
| 151 | MP0000579_abnormal_nail_morphology | 0.73904179 |
| 152 | MP0010307_abnormal_tumor_latency | 0.73884227 |
| 153 | MP0000598_abnormal_liver_morphology | 0.73437974 |
| 154 | MP0003186_abnormal_redox_activity | 0.73199893 |
| 155 | MP0002098_abnormal_vibrissa_morphology | 0.72670810 |
| 156 | MP0002693_abnormal_pancreas_physiology | 0.71122370 |
| 157 | MP0000716_abnormal_immune_system | 0.69440943 |
| 158 | MP0004019_abnormal_vitamin_homeostasis | 0.68860874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 6.29233081 |
| 2 | Abnormal platelet volume (HP:0011876) | 6.07894649 |
| 3 | Prolonged bleeding time (HP:0003010) | 6.07754937 |
| 4 | Menorrhagia (HP:0000132) | 5.44141098 |
| 5 | Neurofibrillary tangles (HP:0002185) | 5.32430025 |
| 6 | Petechiae (HP:0000967) | 5.02456545 |
| 7 | Gingival bleeding (HP:0000225) | 4.75855051 |
| 8 | Epistaxis (HP:0000421) | 4.53129325 |
| 9 | Purpura (HP:0000979) | 4.47774495 |
| 10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.47514414 |
| 11 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.47514414 |
| 12 | Parakeratosis (HP:0001036) | 4.34458425 |
| 13 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.22595261 |
| 14 | Stomatitis (HP:0010280) | 4.04482991 |
| 15 | White forelock (HP:0002211) | 3.85898263 |
| 16 | Patchy hypopigmentation of hair (HP:0011365) | 3.82317523 |
| 17 | Acanthocytosis (HP:0001927) | 3.64997037 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.62566634 |
| 19 | Impaired platelet aggregation (HP:0003540) | 3.57775718 |
| 20 | Abnormal platelet function (HP:0011869) | 3.57775718 |
| 21 | Increased IgM level (HP:0003496) | 3.54799396 |
| 22 | Abnormality of T cell number (HP:0011839) | 3.47534592 |
| 23 | T lymphocytopenia (HP:0005403) | 3.46509312 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.35841751 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.33736386 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.28210801 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.23856935 |
| 28 | Abnormality of the corticospinal tract (HP:0002492) | 3.23137713 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.22557266 |
| 30 | Increased circulating renin level (HP:0000848) | 3.13116858 |
| 31 | Recurrent abscess formation (HP:0002722) | 3.12469024 |
| 32 | Peripheral hypomyelination (HP:0007182) | 3.10739967 |
| 33 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.07912648 |
| 34 | Axonal loss (HP:0003447) | 3.05503254 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 2.99657113 |
| 36 | Poikilocytosis (HP:0004447) | 2.95837460 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.94154516 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.88364989 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.87392640 |
| 40 | Amaurosis fugax (HP:0100576) | 2.80260911 |
| 41 | Onion bulb formation (HP:0003383) | 2.79647315 |
| 42 | Slow saccadic eye movements (HP:0000514) | 2.76183424 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.71901575 |
| 44 | Hypomagnesemia (HP:0002917) | 2.69421781 |
| 45 | Upper limb muscle weakness (HP:0003484) | 2.67892169 |
| 46 | Dyschromatopsia (HP:0007641) | 2.65535602 |
| 47 | Blue irides (HP:0000635) | 2.61186060 |
| 48 | Hypokalemic alkalosis (HP:0001949) | 2.60882015 |
| 49 | Episodic fever (HP:0001954) | 2.60475150 |
| 50 | Papillary thyroid carcinoma (HP:0002895) | 2.59941698 |
| 51 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.56188192 |
| 52 | Granulocytopenia (HP:0001913) | 2.54288185 |
| 53 | Abnormality of B cell number (HP:0010975) | 2.52794792 |
| 54 | Thrombocytosis (HP:0001894) | 2.52691470 |
| 55 | Metabolic alkalosis (HP:0200114) | 2.52612347 |
| 56 | Eczematoid dermatitis (HP:0000976) | 2.50806070 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.49991045 |
| 58 | Cortical dysplasia (HP:0002539) | 2.49667385 |
| 59 | Loss of speech (HP:0002371) | 2.47789154 |
| 60 | Clumsiness (HP:0002312) | 2.47386765 |
| 61 | Abnormality of T cells (HP:0002843) | 2.46446448 |
| 62 | Peripheral demyelination (HP:0011096) | 2.44712771 |
| 63 | Recurrent skin infections (HP:0001581) | 2.39962878 |
| 64 | Abnormal auditory evoked potentials (HP:0006958) | 2.38320911 |
| 65 | IgM deficiency (HP:0002850) | 2.36977210 |
| 66 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.36639818 |
| 67 | Stomach cancer (HP:0012126) | 2.34748694 |
| 68 | Hepatosplenomegaly (HP:0001433) | 2.33979895 |
| 69 | Intrahepatic cholestasis (HP:0001406) | 2.33094051 |
| 70 | Encephalitis (HP:0002383) | 2.31123078 |
| 71 | Eosinophilia (HP:0001880) | 2.29418566 |
| 72 | Retinal dysplasia (HP:0007973) | 2.26130719 |
| 73 | IgG deficiency (HP:0004315) | 2.25029667 |
| 74 | Premature skin wrinkling (HP:0100678) | 2.24001808 |
| 75 | Alacrima (HP:0000522) | 2.22428535 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.20821091 |
| 77 | Leukocytosis (HP:0001974) | 2.20757504 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 2.18675837 |
| 79 | Recurrent viral infections (HP:0004429) | 2.14694547 |
| 80 | Termporal pattern (HP:0011008) | 2.14424739 |
| 81 | Insidious onset (HP:0003587) | 2.14424739 |
| 82 | Anorexia (HP:0002039) | 2.14231114 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14050541 |
| 84 | Arterial thrombosis (HP:0004420) | 2.13574593 |
| 85 | Combined immunodeficiency (HP:0005387) | 2.13341952 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 2.13063796 |
| 87 | Hypophosphatemic rickets (HP:0004912) | 2.10257314 |
| 88 | Sensory axonal neuropathy (HP:0003390) | 2.08375532 |
| 89 | Severe combined immunodeficiency (HP:0004430) | 2.07834943 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06990271 |
| 91 | Abnormality of magnesium homeostasis (HP:0004921) | 2.06280452 |
| 92 | Spastic gait (HP:0002064) | 2.05742064 |
| 93 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05360406 |
| 94 | Prolonged neonatal jaundice (HP:0006579) | 2.05094259 |
| 95 | Joint swelling (HP:0001386) | 2.01233926 |
| 96 | Hypoplasia of the iris (HP:0007676) | 2.00846469 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 2.00605317 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 1.99508853 |
| 99 | Anhidrosis (HP:0000970) | 1.99458438 |
| 100 | Spastic diplegia (HP:0001264) | 1.99242469 |
| 101 | Mucopolysacchariduria (HP:0008155) | 1.98662130 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98662130 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96910862 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96910862 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96910862 |
| 106 | Amyloidosis (HP:0011034) | 1.96634628 |
| 107 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93792546 |
| 108 | Lymphoma (HP:0002665) | 1.93171181 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93137311 |
| 110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93137311 |
| 111 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93137311 |
| 112 | Abnormality of oral frenula (HP:0000190) | 1.92445494 |
| 113 | Uterine leiomyosarcoma (HP:0002891) | 1.90710604 |
| 114 | Leiomyosarcoma (HP:0100243) | 1.90710604 |
| 115 | Cerebral hemorrhage (HP:0001342) | 1.87170076 |
| 116 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.86214511 |
| 117 | Decreased lacrimation (HP:0000633) | 1.84721055 |
| 118 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.84695847 |
| 119 | Hypothermia (HP:0002045) | 1.83719286 |
| 120 | Autoimmune hemolytic anemia (HP:0001890) | 1.83424237 |
| 121 | Pheochromocytoma (HP:0002666) | 1.82122989 |
| 122 | Increased density of long bones (HP:0006392) | 1.82066144 |
| 123 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81853550 |
| 124 | Ocular albinism (HP:0001107) | 1.81113921 |
| 125 | Seborrheic dermatitis (HP:0001051) | 1.80877083 |
| 126 | Autoamputation (HP:0001218) | 1.80643636 |
| 127 | Abnormal large intestine physiology (HP:0012700) | 1.78964229 |
| 128 | Abnormality of homocysteine metabolism (HP:0010919) | 1.77797642 |
| 129 | Homocystinuria (HP:0002156) | 1.77797642 |
| 130 | Hypercholesterolemia (HP:0003124) | 1.77077236 |
| 131 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76223742 |
| 132 | Enlarged epiphyses (HP:0010580) | 1.76043505 |
| 133 | Paraparesis (HP:0002385) | 1.75451789 |
| 134 | Thrombophlebitis (HP:0004418) | 1.74967768 |
| 135 | Erythroderma (HP:0001019) | 1.74749513 |
| 136 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74645394 |
| 137 | Premature ovarian failure (HP:0008209) | 1.74613754 |
| 138 | Hypoplastic pelvis (HP:0008839) | 1.73105537 |
| 139 | Spastic paraparesis (HP:0002313) | 1.72701615 |
| 140 | Ankyloglossia (HP:0010296) | 1.71694285 |
| 141 | Pulmonary embolism (HP:0002204) | 1.71541833 |
| 142 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.70894871 |
| 143 | Abnormality of renin-angiotensin system (HP:0000847) | 1.70748833 |
| 144 | Type II lissencephaly (HP:0007260) | 1.70735149 |
| 145 | Gastrointestinal stroma tumor (HP:0100723) | 1.68883468 |
| 146 | Hypobetalipoproteinemia (HP:0003563) | 1.68703973 |
| 147 | Pallor (HP:0000980) | 1.68197842 |
| 148 | Hypoglycemic seizures (HP:0002173) | 1.68193201 |
| 149 | Chest pain (HP:0100749) | 1.68074146 |
| 150 | Tinnitus (HP:0000360) | 1.68056290 |
| 151 | Abnormality of the prostate (HP:0008775) | 1.67836502 |
| 152 | Xanthomatosis (HP:0000991) | 1.67781910 |
| 153 | Meningitis (HP:0001287) | 1.67573362 |
| 154 | IgA deficiency (HP:0002720) | 1.66951135 |
| 155 | Inflammation of the large intestine (HP:0002037) | 1.66735456 |
| 156 | Neuroendocrine neoplasm (HP:0100634) | 1.66599469 |
| 157 | Gastrointestinal inflammation (HP:0004386) | 1.66534518 |
| 158 | Supernumerary ribs (HP:0005815) | 1.66482777 |
| 159 | Opisthotonus (HP:0002179) | 1.65214817 |
| 160 | Vasculitis (HP:0002633) | 1.64858350 |
| 161 | Cupped ear (HP:0000378) | 1.64316636 |
| 162 | Akinesia (HP:0002304) | 1.63968785 |
| 163 | Absent septum pellucidum (HP:0001331) | 1.63488886 |
| 164 | Vascular calcification (HP:0004934) | 1.63382818 |
| 165 | Cerebral hypomyelination (HP:0006808) | 1.62699246 |
| 166 | Tetany (HP:0001281) | 1.62665990 |
| 167 | Abnormality of T cell physiology (HP:0011840) | 1.62363605 |
| 168 | Viral hepatitis (HP:0006562) | 1.62226342 |
| 169 | Urticaria (HP:0001025) | 1.62060270 |
| 170 | Myositis (HP:0100614) | 1.61626915 |
| 171 | Spontaneous abortion (HP:0005268) | 1.61034640 |
| 172 | Hypoplasia of the thymus (HP:0000778) | 1.60723005 |
| 173 | Microvesicular hepatic steatosis (HP:0001414) | 1.60235453 |
| 174 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.59341467 |
| 175 | Recurrent fungal infections (HP:0002841) | 1.58543383 |
| 176 | Abnormality of eosinophils (HP:0001879) | 1.57732656 |
| 177 | Hypophosphatemia (HP:0002148) | 1.57228499 |
| 178 | Stridor (HP:0010307) | 1.56816413 |
| 179 | Retinal atrophy (HP:0001105) | 1.56726147 |
| 180 | Submucous cleft hard palate (HP:0000176) | 1.56370568 |
| 181 | Partial agenesis of the corpus callosum (HP:0001338) | 1.55790424 |
| 182 | Rickets (HP:0002748) | 1.54391216 |
| 183 | Elevated alkaline phosphatase (HP:0003155) | 1.54310709 |
| 184 | Obstructive lung disease (HP:0006536) | 1.52909693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 4.72499109 |
| 2 | RIPK4 | 4.33375797 |
| 3 | STK39 | 4.15136288 |
| 4 | EIF2AK1 | 3.58364282 |
| 5 | OXSR1 | 2.92613402 |
| 6 | BMPR2 | 2.66986798 |
| 7 | MET | 2.55541212 |
| 8 | MAPKAPK5 | 2.55216272 |
| 9 | TAOK3 | 2.23880232 |
| 10 | PASK | 2.21747098 |
| 11 | WNK4 | 2.18307809 |
| 12 | SRPK1 | 2.03743252 |
| 13 | MAP3K10 | 1.99486904 |
| 14 | MAPK15 | 1.96646807 |
| 15 | CDK12 | 1.92961800 |
| 16 | MST4 | 1.89790440 |
| 17 | NTRK1 | 1.86202620 |
| 18 | GRK6 | 1.82352511 |
| 19 | PBK | 1.79721176 |
| 20 | SCYL2 | 1.75037095 |
| 21 | MAP4K1 | 1.75024782 |
| 22 | MAP3K14 | 1.62186307 |
| 23 | EPHA3 | 1.60817437 |
| 24 | CSNK1A1L | 1.60620553 |
| 25 | RAF1 | 1.59935802 |
| 26 | MST1R | 1.57174101 |
| 27 | BLK | 1.56513471 |
| 28 | EEF2K | 1.49577697 |
| 29 | CSNK1G3 | 1.48704612 |
| 30 | TXK | 1.47019397 |
| 31 | FGR | 1.46359680 |
| 32 | KSR2 | 1.44149163 |
| 33 | PKN1 | 1.43193779 |
| 34 | CDK6 | 1.42425875 |
| 35 | CLK1 | 1.40491123 |
| 36 | INSRR | 1.38161750 |
| 37 | IRAK4 | 1.37938152 |
| 38 | CSNK1G1 | 1.33258152 |
| 39 | STK10 | 1.31191867 |
| 40 | HIPK2 | 1.28908619 |
| 41 | TBK1 | 1.26260195 |
| 42 | BRD4 | 1.21448601 |
| 43 | BCR | 1.19809991 |
| 44 | SMG1 | 1.19629927 |
| 45 | YES1 | 1.18722665 |
| 46 | SIK3 | 1.18269411 |
| 47 | ITK | 1.13878249 |
| 48 | IKBKE | 1.10365826 |
| 49 | CDC7 | 1.10233419 |
| 50 | IRAK1 | 1.10126524 |
| 51 | TESK2 | 1.09263791 |
| 52 | GSK3A | 1.09105324 |
| 53 | ALK | 1.05695325 |
| 54 | CDK4 | 1.05217359 |
| 55 | TTK | 1.03579459 |
| 56 | CAMKK2 | 1.00842238 |
| 57 | FGFR2 | 1.00807920 |
| 58 | CSNK1G2 | 0.99817539 |
| 59 | ZAP70 | 0.99541147 |
| 60 | MAP2K3 | 0.97096910 |
| 61 | LCK | 0.97002581 |
| 62 | BTK | 0.94672902 |
| 63 | UHMK1 | 0.94019445 |
| 64 | BMPR1B | 0.93894762 |
| 65 | MATK | 0.93615037 |
| 66 | CSK | 0.92918257 |
| 67 | DYRK2 | 0.92372519 |
| 68 | RPS6KB2 | 0.91969002 |
| 69 | SGK494 | 0.89492384 |
| 70 | SGK223 | 0.89492384 |
| 71 | RPS6KA5 | 0.88390591 |
| 72 | PRKCQ | 0.88010241 |
| 73 | CAMK1G | 0.85858813 |
| 74 | KIT | 0.84376988 |
| 75 | MAP2K2 | 0.83797205 |
| 76 | MARK2 | 0.83208997 |
| 77 | IKBKB | 0.82352036 |
| 78 | WNK3 | 0.82236984 |
| 79 | WNK1 | 0.81918212 |
| 80 | IRAK3 | 0.81227281 |
| 81 | PIM1 | 0.79268020 |
| 82 | ICK | 0.78766815 |
| 83 | NEK6 | 0.76517254 |
| 84 | FGFR4 | 0.75749287 |
| 85 | STK24 | 0.74430136 |
| 86 | CAMK2B | 0.73966053 |
| 87 | MAP3K13 | 0.71573688 |
| 88 | CSF1R | 0.69192152 |
| 89 | TYRO3 | 0.67748654 |
| 90 | CAMK2D | 0.67103575 |
| 91 | MAPKAPK3 | 0.64441479 |
| 92 | BMX | 0.64312478 |
| 93 | JAK1 | 0.63740245 |
| 94 | CDK19 | 0.63553380 |
| 95 | MARK3 | 0.63098336 |
| 96 | PRKCE | 0.63010181 |
| 97 | EPHA2 | 0.62508111 |
| 98 | NLK | 0.62284843 |
| 99 | FLT3 | 0.61451964 |
| 100 | LYN | 0.61237763 |
| 101 | PTK2 | 0.61094994 |
| 102 | STK4 | 0.60995974 |
| 103 | TYK2 | 0.60991154 |
| 104 | NUAK1 | 0.60457284 |
| 105 | TAOK2 | 0.60258466 |
| 106 | PDK2 | 0.60082475 |
| 107 | TEC | 0.59736488 |
| 108 | CAMKK1 | 0.59547080 |
| 109 | HCK | 0.59533769 |
| 110 | PAK2 | 0.58726709 |
| 111 | JAK3 | 0.57899155 |
| 112 | FYN | 0.57710683 |
| 113 | PAK4 | 0.57168091 |
| 114 | MAP3K8 | 0.56365827 |
| 115 | PNCK | 0.55285222 |
| 116 | JAK2 | 0.55187373 |
| 117 | DAPK1 | 0.53199402 |
| 118 | PIK3CG | 0.53114961 |
| 119 | MAPK11 | 0.53100189 |
| 120 | PDPK1 | 0.53063521 |
| 121 | SYK | 0.52785744 |
| 122 | MUSK | 0.51167441 |
| 123 | LATS1 | 0.50972702 |
| 124 | ARAF | 0.50716452 |
| 125 | MAP3K9 | 0.49832670 |
| 126 | RPS6KA4 | 0.49022803 |
| 127 | PDK1 | 0.48103438 |
| 128 | IRAK2 | 0.47996417 |
| 129 | FES | 0.47932854 |
| 130 | ILK | 0.47867663 |
| 131 | GRK7 | 0.47833579 |
| 132 | PIM2 | 0.47799068 |
| 133 | PDGFRB | 0.47123830 |
| 134 | TGFBR2 | 0.46753033 |
| 135 | INSR | 0.45882731 |
| 136 | ABL1 | 0.45336216 |
| 137 | TNIK | 0.44120548 |
| 138 | ERN1 | 0.43923016 |
| 139 | ADRBK2 | 0.43540886 |
| 140 | STK3 | 0.42990399 |
| 141 | MAP3K2 | 0.42946186 |
| 142 | ERBB4 | 0.42875954 |
| 143 | TAOK1 | 0.42733107 |
| 144 | RET | 0.42729357 |
| 145 | ROCK2 | 0.42666271 |
| 146 | CDK7 | 0.42616743 |
| 147 | IGF1R | 0.42274821 |
| 148 | PRPF4B | 0.42270374 |
| 149 | PTK6 | 0.42171368 |
| 150 | MAP3K1 | 0.42105999 |
| 151 | TRPM7 | 0.41977430 |
| 152 | RPS6KB1 | 0.40067116 |
| 153 | MAP3K5 | 0.40007903 |
| 154 | CDK14 | 0.39175183 |
| 155 | CHEK1 | 0.38641855 |
| 156 | KSR1 | 0.37862978 |
| 157 | MAPKAPK2 | 0.36625226 |
| 158 | NEK1 | 0.36443152 |
| 159 | TRIM28 | 0.33649785 |
| 160 | CSNK2A2 | 0.33412798 |
| 161 | EGFR | 0.32850348 |
| 162 | PAK1 | 0.30749410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.55558262 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.24621452 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.05075358 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.36971885 |
| 5 | Platelet activation_Homo sapiens_hsa04611 | 3.15220034 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.86951677 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.79601034 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.60230655 |
| 9 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.49272783 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.47327957 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.47307593 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.45513446 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.39636655 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.39189407 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.33057248 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 2.24869895 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.00923762 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.00142875 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93503503 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.92626871 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.89292046 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.88560337 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.87333028 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.77851417 |
| 25 | DNA replication_Homo sapiens_hsa03030 | 1.67439185 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.66188013 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.63141301 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.51246628 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.50149614 |
| 30 | Cell cycle_Homo sapiens_hsa04110 | 1.48087265 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.47835447 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.47344232 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45492784 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.42840452 |
| 35 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.42158890 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34618074 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32439404 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28764189 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28724470 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27123595 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.25226538 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24425912 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19611406 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.19448506 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14845268 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12344191 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.11830694 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10046627 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07957097 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07209957 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06171946 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05359631 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04924081 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04752767 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 1.04168019 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03282427 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.02403216 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.01892243 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99620841 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99131708 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99076145 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98626554 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98297630 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97452684 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95827722 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.93763814 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.93103858 |
| 68 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.92454059 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92259838 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91835983 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90855542 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88435235 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.87320801 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86681646 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86322400 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86081224 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84839229 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84069210 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83067484 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82823441 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82422774 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81936304 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80562637 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80133526 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.79512626 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79426230 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78928908 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78903371 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77879843 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77743025 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.77204695 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77160017 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.76900732 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76685900 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75590234 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.75307919 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.74802037 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74132791 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71030872 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.70574292 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70307973 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67145554 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66685146 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66070017 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65627441 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63154367 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62823994 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62666870 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62522459 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62027400 |
| 111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61632706 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.61580078 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.61548485 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.61231446 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61099471 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60539807 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58747675 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.57589404 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57258458 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56648326 |
| 121 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56484483 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.56399765 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56315970 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55963248 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.55492762 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53692617 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52931029 |
| 128 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52578371 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51695845 |
| 130 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51221912 |
| 131 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50971546 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50156143 |
| 133 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49942642 |
| 134 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49909971 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49531294 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49326997 |
| 137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48872397 |
| 138 | Legionellosis_Homo sapiens_hsa05134 | 0.48730554 |
| 139 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47942054 |
| 140 | Axon guidance_Homo sapiens_hsa04360 | 0.47605926 |
| 141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47391905 |
| 142 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47145193 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46646709 |
| 144 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45399722 |
| 145 | Measles_Homo sapiens_hsa05162 | 0.45214556 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.44456120 |
| 147 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43882745 |
| 148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42715713 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42346697 |
| 150 | Influenza A_Homo sapiens_hsa05164 | 0.41628844 |
| 151 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41082313 |
| 152 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41021411 |
| 153 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38936077 |
| 154 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.38708117 |
| 155 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38430449 |
| 156 | Melanoma_Homo sapiens_hsa05218 | 0.37381943 |
| 157 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37317711 |
| 158 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35774924 |
| 159 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.34888022 |
| 160 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34746931 |
| 161 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34709719 |
| 162 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34480823 |
| 163 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34000528 |
| 164 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33533627 |
| 165 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33387827 |
| 166 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31824630 |
| 167 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30919082 |
| 168 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30268915 |
| 169 | Salmonella infection_Homo sapiens_hsa05132 | 0.29812556 |
| 170 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26264245 |
| 171 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24253178 |
| 172 | Bile secretion_Homo sapiens_hsa04976 | 0.23839033 |

